PubRank

G van der Groen

Author PubWeight™ 126.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 1993 3.52
2 Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire. Lancet 1977 2.65
3 Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol 1995 2.48
4 Hemorrhagic fever with renal syndrome. Prog Med Virol 1989 2.38
5 Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol 1994 2.29
6 Sequence analysis of a highly divergent HIV-1-related lentivirus isolated from a wild captured chimpanzee. Virology 1996 1.91
7 Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology 1982 1.89
8 Detection of human immunodeficiency virus type 1 (HIV-1) in heel prick blood on filter paper from children born to HIV-1-seropositive mothers. J Clin Microbiol 1994 1.81
9 Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1. J Virol 1998 1.75
10 Characterization of Dobrava virus: a Hantavirus from Slovenia, Yugoslavia. J Med Virol 1992 1.73
11 Confirmation and differentiation of antibodies to human immunodeficiency virus 1 and 2 with a strip-based assay including recombinant antigens and synthetic peptides. Clin Chem 1991 1.73
12 Isolation and characterization of a new chimpanzee lentivirus (simian immunodeficiency virus isolate cpz-ant) from a wild-captured chimpanzee. AIDS 1992 1.72
13 Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs. J Infect Dis 2000 1.52
14 Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers. J Clin Microbiol 1999 1.51
15 Multivariate analysis of human immunodeficiency virus type 1 neutralization data. J Virol 1996 1.41
16 Comparative evaluation of 36 commercial assays for detecting antibodies to HIV. Bull World Health Organ 1991 1.40
17 Sensitivity of HIV-antibody assays determined by seroconversion panels. AIDS 1994 1.37
18 Design and evaluation of new, highly sensitive and specific primers for polymerase chain reaction detection of HIV-1 infected primary lymphocytes. Mol Cell Probes 1994 1.32
19 Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates. J Med Virol 2000 1.31
20 HIV antigen detection in circulating immune complexes. J Virol Methods 1991 1.30
21 Ebola virus virulence for newborn mice. J Med Virol 1979 1.26
22 Isolation of simian immunodeficiency viruses from two sooty mangabeys in Côte d'Ivoire: virological and genetic characterization and relationship to other HIV type 2 and SIVsm/mac strains. AIDS Res Hum Retroviruses 1994 1.25
23 Ecological and epidemiological data on Hantavirus in bank vole populations in Belgium. Arch Virol 1986 1.24
24 Phylogenetic analysis of a new chimpanzee lentivirus SIVcpz-gab2 from a wild-captured chimpanzee from Gabon. AIDS Res Hum Retroviruses 1994 1.21
25 What role does HIV-1 subtype play in transmission and pathogenesis? An epidemiological perspective. AIDS 1999 1.18
26 Longstanding presence in Belgians of multiple non-B HIV-1 subtypes. Lancet 1996 1.17
27 A search for Ebola virus in animals in the Democratic Republic of the Congo and Cameroon: ecologic, virologic, and serologic surveys, 1979-1980. Ebola Virus Study Teams. J Infect Dis 1999 1.17
28 Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection. J Clin Immunol 1991 1.15
29 Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS 1998 1.14
30 Virological and polymerase chain reaction studies of HIV-1/HIV-2 dual infection in Côte d'Ivoire. Lancet 1992 1.11
31 Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D. AIDS Res Hum Retroviruses 1995 1.10
32 Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes. J Virol Methods 1997 1.08
33 Isolation of HIV-1 RNA from plasma: evaluation of seven different methods for extraction (part two). J Virol Methods 1998 1.08
34 A look at the P4 virus containment laboratory. Prog Med Virol 1982 1.07
35 Risk factors for infection with human immmunodeficiency virus among European expatriates in Africa. BMJ 1988 1.05
36 Comparison of enzyme immunoassays and an immunofluorescence test for detection of antibody to human immunodeficiency virus in African sera. Eur J Clin Microbiol 1987 1.04
37 Quantification of human immunodeficiency virus in plasma by RNA PCR, viral culture, and p24 antigen detection. J Clin Microbiol 1994 1.01
38 Algorithms for detecting antibodies to HIV-1: results from a rural Ugandan cohort. AIDS 1993 1.00
39 Modeling HIV transfer between dendritic cells and T cells: importance of HIV phenotype, dendritic cell-T cell contact and T-cell activation. AIDS 2000 1.00
40 Modifications to indirect immunofluorescence tests on Lassa, Marburg, and Ebola material. Lancet 1983 1.00
41 Replication of arboviruses in mouse organ cultures. II. Multiplication of virulent and avirulent Semliki Forest and western equine encephalitis viruses in mouse organ cultures. Arch Virol 1975 0.99
42 Molecular phylogeny of part of the env gene of HIV-1 strains isolated in Côte d'Ivoire. AIDS 1994 0.98
43 Interaction of mouse peritoneal macrophages with different arboviruses in vitro. J Gen Virol 1977 0.97
44 HIV-1 subtypes and the HIV epidemics in four cities in sub-Saharan Africa. AIDS 2001 0.97
45 Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I/II) in Gabon: a prospective follow-up of 4 years. J Acquir Immune Defic Syndr Hum Retrovirol 1996 0.95
46 Differences in early virus loads with different phenotypic variants of HIV-1 and SIV(cpz) in chimpanzees. AIDS 2001 0.95
47 Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assay. J Virol Methods 1998 0.95
48 Isolation of HIV-1 RNA from plasma: evaluation of eight different extraction methods. J Virol Methods 1996 0.95
49 Potent broad cross-neutralizing sera inhibit attachment of primary HIV-1 isolates (groups M and O) to peripheral blood mononuclear cells. Virology 2001 0.94
50 Comparison of immunofluorescence and enzyme-linked immunosorbent assays for the serology of Hantaan virus infections. J Virol Methods 1989 0.93
51 Study of HIV type 1 gag/env variability in The Gambia, using a multiplex DNA polymerase chain reaction. AIDS Res Hum Retroviruses 2000 0.93
52 Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo. AIDS Res Hum Retroviruses 2000 0.92
53 Epidemiological and molecular characteristics of HIV infection in Gabon, 1986-1994. AIDS 1996 0.90
54 Evaluation of immunofluorescence and immunoperoxidase methods for antibody determination against Chikungunya, West Nile and yellow fever viruses. Ann Soc Belg Med Trop 1979 0.89
55 Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing. AIDS 1998 0.89
56 Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group O. J Med Virol 1997 0.89
57 Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant. J Virol 1997 0.89
58 Intrapatient variability of HIV type 1 group O ANT70 during a 10-year follow-up. AIDS Res Hum Retroviruses 1999 0.88
59 Different hantavirus serotypes in western Europe. Lancet 1991 0.88
60 Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection. J Infect Dis 1995 0.87
61 Isolation in Vero-E6 cells of Hanta virus from Clethrionomys glareolus captured in the Bashkiria area of the U.S.S.R. Ann Soc Belg Med Trop 1984 0.87
62 Genetic characterization of Puumala hantavirus strains from Belgium: evidence for a distinct phylogenetic lineage. Virus Res 2001 0.87
63 Improved detection of HIV-2 proviral DNA in dually seroreactive individuals by PCR. AIDS 1998 0.87
64 Interpatient genetic variability of HIV-1 group O. AIDS 1999 0.86
65 HIV-1 genetic variability in Cameroon. AIDS 2000 0.86
66 Haemorrhagic fever with renal syndrome: evaluation of ELISA for detection of Puumala-virus-specific IgG and IgM. Res Virol 1991 0.86
67 Evaluation and comparison of the Amplicor HIV-1 PCR kit with an 'in-house' nested PCR. Clin Diagn Virol 1995 0.85
68 Virtually full-length subtype F and F/D recombinant HIV-1 from Africa and South America. Virology 2000 0.85
69 Independent introduction of transmissible F/D recombinant HIV-1 from Africa into Belgium and The Netherlands. Virology 2000 0.85
70 Enzyme immuno assay for the detection of virus specific IgG and IgM antibody in patients with haemorrhagic fever with renal syndrome. Arch Virol 1988 0.84
71 The neutralization relationship of HIV type 1, HIV type 2, and SIVcpz is reflected in the genetic diversity that distinguishes them. AIDS Res Hum Retroviruses 1997 0.84
72 Serological detection of infection with diverse human and simian immunodeficiency viruses using consensus env peptides. Clin Diagn Lab Immunol 2000 0.84
73 Reanalysis of full-length HIV type 1 group M subtype K and sub-subtype F2 with an MS-DOS bootscanning program. AIDS Res Hum Retroviruses 2001 0.84
74 Longitudinal comparison of virus load parameters and CD8 T-cell suppressive capacity in two SIVcpz-infected chimpanzees. J Med Primatol 2001 0.84
75 HIV type 1 C2V3 env diversity among Belgian individuals. AIDS Res Hum Retroviruses 1998 0.83
76 Genetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturally. J Med Virol 2001 0.83
77 Partial characterization of a Hantavirus isolated from a Clethrionomys glareolus captured in Belgium. Acta Virol 1987 0.83
78 Hemorrhagic fever with renal syndrome in a Canadian serviceman. CMAJ 1990 0.82
79 Phylogenetic analysis of protease and transmembrane region of HIV type 1 group O. AIDS Res Hum Retroviruses 2000 0.81
80 Development of a one-tube multiplex reverse transcriptase-polymerase chain reaction assay for the simultaneous amplification of HIV type 1 group M gag and env heteroduplex mobility assay fragments. AIDS Res Hum Retroviruses 2000 0.81
81 Dendritic cells, exposed to primary, mixed phenotype HIV-1 isolates preferentially, but not exclusively, replicate CCR5-using clones. AIDS 2000 0.81
82 Acute hantavirus nephropathy in Belgium: preliminary results of a sero-epidemiological study. Adv Exp Med Biol 1987 0.81
83 Differential diagnosis of HIV type 1 group O and M infection by polymerase chain reaction and PstI restriction analysis of the pol gene fragment. AIDS Res Hum Retroviruses 1998 0.81
84 Line immunoassay and enzyme-linked line immunofiltration assay for simultaneous detection of antibody to two treponemal antigens. Eur J Clin Microbiol Infect Dis 1989 0.81
85 [Indirect immunoenzyme method for the laboratory diagnosis of Lassa and Ebola hemorrhagic fevers]. Vopr Virusol 1986 0.81
86 How many different HIV-1 viral load test kits do we need? AIDS 1998 0.81
87 Haemorrhagic fever with renal syndrome: recent developments. Ann Soc Belg Med Trop 1985 0.81
88 Alternative confirmatory strategy for anti-HIV antibody detection. J Virol Methods 1992 0.81
89 Evaluation of an agglutination HIV-1 + 2 antibody assay. J Virol Methods 1995 0.81
90 Diagnosis of epidemic and sporadic interstitial nephritis due to Hantaan-like virus in Belgium. Lancet 1984 0.81
91 HIV-1 group O and group M dual infection in Bénin. Lancet 1996 0.81
92 A simplified and less expensive strategy for confirming anti HIV-1 screening results in a diagnostic laboratory in Lubumbashi, Zaire. Ann Soc Belg Med Trop 1991 0.80
93 Characterization of some ungrouped viruses. Trans R Soc Trop Med Hyg 1981 0.80
94 Macrophage-tropism of HIV-1 isolates of different genetic subtypes. AIDS 1997 0.80
95 Detection of HIV-1 antibodies in blood specimens spotted on filter-paper. Bull World Health Organ 1992 0.80
96 Cross-neutralizing antibodies to HIV-1ANT70 and HIV-1IIIB in sera of African and Belgian HIV-1-infected individuals. AIDS 1994 0.79
97 Selection of human anti-human immunodeficiency virus type 1 envelope single-chain antibodies from a peripheral blood cell-based phage repertoire. J Gen Virol 1998 0.79
98 HIV screening and confirmation: a simplified and less expensive testing algorithm. Ann Soc Belg Med Trop 1992 0.79
99 Hantavirus nephropathy in Netherlands. Lancet 1989 0.79
100 Phylogenetic analysis of the env gene of HIV-1 isolates taking into account individual nucleotide substitution rates. AIDS 1996 0.78
101 Genetic and antigenic variability of HIV type 1 in Brazil. AIDS Res Hum Retroviruses 1994 0.78
102 A comparison of indirect immunofluorescence and electron microscopy for the diagnosis of some haemorrhagic viruses in cell cultures. J Virol Methods 1981 0.78
103 International Colloquium on Ebola Virus Research: summary report. J Infect Dis 1997 0.78
104 Focus of muroid virus nephropathy in France. Lancet 1984 0.78
105 Epidemiology and laboratory diagnosis of hantavirus (HTV) infections. Acta Clin Belg 1995 0.78
106 HIV-1 subtype H near-full length genome reference strains and analysis of subtype-H-containing inter-subtype recombinants. AIDS 2000 0.78
107 Evaluation of a line immunoassay for simultaneous confirmation of antibodies to HIV-1 and HIV-2. Eur J Clin Microbiol Infect Dis 1991 0.78
108 [Hantavirus infections in the Netherlands]. Ned Tijdschr Geneeskd 1984 0.78
109 Eradication of hantavirus infection among laboratory rats by application of caesarian section and a foster mother technique. J Infect 1992 0.78
110 Evaluation of different V3 peptides in an enzyme immunoassay for specific HIV type 1 group O antibody detection. AIDS Res Hum Retroviruses 1998 0.78
111 Hantavirus disease. Lancet 1984 0.77
112 Evaluation of a newly developed HIV antigen test. J Med Virol 1997 0.77
113 Presence of HIV-1 group O infection in West Africa. AIDS 1996 0.77
114 Viewpoint: filovirus haemorrhagic fever outbreaks: much ado about nothing? Trop Med Int Health 2000 0.77
115 A pilot study of the prevalence of hepatitis C virus antibodies and hepatitis C virus RNA in southern Cameroon. Am J Trop Med Hyg 1995 0.77
116 Seroepidemiology of Hantaan-related virus infections in Belgian populations. Lancet 1984 0.76
117 Failure to infect lower primate species with SIVcpz. AIDS 1995 0.76
118 HIV-1 group O infection in Belgium. Acta Clin Belg 1995 0.76
119 Evidence for Hantavirus disease in Slovenia, Yugoslavia. Acta Virol 1989 0.75
120 Acute non-cardiogenic pulmonary edema in a 2003 French Puumala virus case: cautions and corrections. Clin Nephrol 2004 0.75
121 An inhibition enzyme immunoassay using a human monoclonal antibody (K14) reactive with gp41 of HIV-1 for the serology of HIV-1 infections. AIDS 1991 0.75
122 Puumala virus reference strain for hantavirus serodiagnosis in France. Eur J Clin Microbiol Infect Dis 2010 0.75
123 Immunoperoxidase assay for the detection of specific IgG antibodies to Hantaan virus. J Virol Methods 1985 0.75
124 Infectious virus titer, replicative and syncytium-inducing capacity of human immunodeficiency virus type 1. J Med Virol 1995 0.75
125 Design and evaluation of new, highly sensitive and specific primers for polymerase chain reaction detection of HIV-1 infected primary lymphocytes. Mol Cell Probes 1995 0.75
126 Variability among HIV and SIV strains of African origin. AIDS 1991 0.75
127 Bangui, Bobaya, Zinga, Trinity, Kowanyama and Strain AnY 1444 virus : electron microscopy, physico-chemical characterization and classification [proceedings]. Arch Int Physiol Biochim 1979 0.75
128 Negative-pressure flexible film isolator for work with class IV viruses in a maximum security laboratory. J Infect 1980 0.75
129 Evaluation of four HIV antigen tests. J Virol Methods 2001 0.75
130 Haemorrhagic fever with renal syndrome related virus in indigenous wild rodents in Belgium. Lancet 1983 0.75
131 Use of a rapid test and an ELISA for HIV antibody screening of pooled serum samples in Lubumbashi, Zaire. J Virol Methods 1993 0.75
132 [Evaluation of the results of a direct solid-phase immunoenzyme method for determining antigens]. Vopr Virusol 1987 0.75
133 Quantitative assay for group M (subtype A-H) and group O HIV-1 RNA detection in plasma. J Virol Methods 2001 0.75
134 [Antigenic analysis of hemorrhagic fever with renal syndrome viruses (HFRS) using monoclonal antibodies]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1987 0.75
135 HIV-1 infection in HIV-1 enzyme-linked immunoassay seronegative patients in Kinshasa, Zaire. Int J STD AIDS 1990 0.75
136 Application of concanavalin A for the detection of enveloped viruses by electronmicroscopy (the lectin pseudoreplica technique). Ann Soc Belg Med Trop 1979 0.75
137 Antibodies to V3 loop peptides derived from chimpanzee lentiviruses and the divergent HIV-1ANT-70 isolate in human sera from different geographic regions. AIDS 1994 0.75
138 [Method for the simultaneous detection of immunofluorescing antibodies to the causative agents of different hemorrhagic fevers]. Vopr Virusol 1986 0.75
139 Delayed multiplication of Semliki forest virus in organ cultures of muscle from vaccinated mice. Zentralbl Bakteriol Orig A 1976 0.75
140 AIDS in Africa: a public health priority. J Virol Methods 1987 0.75
141 Evaluation of two enzyme immunoassays for detection of human immunodeficiency virus antigen in African and European sera. Eur J Clin Microbiol Infect Dis 1989 0.75
142 Recent increase in diagnoses of HIV infections based on surveillance system data in Belgium. AIDS 2000 0.75
143 Near full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinants. AIDS Res Hum Retroviruses 2000 0.75
144 Hantavirus nephropathy in Western Europe: ubiquity of hemorrhagic fevers with renal syndrome. Adv Nephrol Necker Hosp 1986 0.75
145 The urgent need for feasibility studies of antiretroviral treatment in HIV-infected individuals in resource-limited settings. AIDS 2001 0.75
146 [The biological properties of the HIV isolated from a virus carrier living in the Byelorussian SSR]. Vopr Virusol 1991 0.75
147 Indirect immunofluorescence and electronmicroscopy for the diagnosis of yellow fever virus infection. Ann Soc Belg Med Trop 1978 0.75